...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30, 2019

Free
Message: Any thoughts on this poster?

"However, the mouse data are new I believe. Exciting that apabetalone elicits decreased inflammation in the brain of LPS treated mice!"

My bad. They presented this mouse data earlier this year at AD/PD. Much of the cellular work has been presented before too. So nothing earth shattering new in this upcoming SfN poster.

https://www.resverlogix.com/upload/media_element/164/c6c479d2184e/ad-pd-2019-poster-final.pdf

BDAZ

Share
New Message
Please login to post a reply